Get started
Author

Ansgar Resch

Aptamers—basic research, drug development, and clinical applications
2005 · Daniela Proske, Michael Blank, et al. · Applied Microbiology and Biotechnology · 280
The cost of resistance: incremental cost of methicillin-resistant Staphylococcus aureus (MRSA) in German hospitals
2008 · Ansgar Resch, Michael Wilke, et al. · The European Journal of Health Economics · 82
Antithrombogenic Coating of Stents Using a Biodegradable Drug Delivery Technology
1999 · R. Herrmann, G. Schmidmaier, et al. · Thrombosis and Haemostasis · 65
The Economic Costs of Overactive Bladder in Germany
2006 · Theodor Klotz, Bernd Brüggenjürgen, et al. · European Urology · 56
Burden of pulmonary arterial hypertension in Germany
2010 · H. Wilkens, F. Grimminger, et al. · Respiratory Medicine · 53
Cost-Effectiveness of Linezolid vs Vancomycin in Suspected Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia in Germany
2009 · E. De Cock, W. A. Krueger, et al. · Infection · 45
Economic Evaluation of Voriconazole versus Conventional Amphotericin B in the Treatment of Invasive Aspergillosis in Germany
2006 · Jeroen P. Jansen, Winfried V. Kern, et al. · Value in Health · 34
Clinical Implications and Economic Impact of Accuracy Differences among Commercially Available Blood Glucose Monitoring Systems
2013 · Erwin S. Budiman, Navendu Samant, et al. · Journal of Diabetes Science and Technology · 30
Cost-effectiveness of linezolid versus vancomycin for hospitalised patients with complicated skin and soft-tissue infections in Germany
2008 · Dirk Schürmann, Sonja V. Sorensen, et al. · The European Journal of Health Economics · 27
Thrombogenicity of stainless steel coronary stents with a completely gold coated surface
1998 · R.A. Herrmann, A. Rybnikar, et al. · Journal of the American College of Cardiology · 12
PDF
Actionable Self-Monitoring of Blood Glucose: Redefining the Role for Patients Using Multiple Daily Injection Therapy
2011 · David Kerr, Rebecca Messing, et al. · Journal of Diabetes Science and Technology · 8
Triple-coated stents (Hirudin/Iloprost/Paclitaxel): an in vitro approach for characterizing the antiproliferative potential of each individual compound
2004 · Rainer Voisard, Axel Stemberger, et al. · International Journal of Cardiology · 7
Pin2 Cost-effectiveness of Linezolid Versus Vancomycin in Suspected Methicillin-resistant Staphylococcus Aureus in Nosocomial Pneumonia in Germany
2004 · T Grünewald, E De Cock, et al. · Value in Health · 6
PDF
Die Effizienz der Behandlung der Schizophrenie mit Ziprasidon im Vergleich zu anderen Neuroleptika unter Berücksichtigung von Arzneimittelnebenwirkungen und Noncompliance
2005 · H.-P Volz, M Sadre-Chirazi-Stark, et al. · Gesundheitsökonomie & Qualitätsmanagement · 4
Pin3 Linezolid for the Treatment of Skin and Soft-tissue Mrsa Infections—a Cost-effective Alternative to Vancomycin: Evidence From a Multinational Clinical Trial
2004 · SV Sorensen, CS Hollenbeak, et al. · Value in Health · 4
PDF
Konsequenzen der Genauigkeit von Blutglucosemesssystemen
2014 · F. Hessel, G. Freckmann, et al. · Der Diabetologe · 3
Prs6 Economic Burden of Disease of Pulmonary Arterial Hypertension in Germany: an Interim Analysis of Resource Utilisation
2007 · B Ehlken, C Plesnila Frank, et al. · Value in Health · 2
PDF
Puk7 Delivering Treatment Effectiveness: Costs and Persistence of Tolterodine in the Management of Oab in Five European Countries
2005 · P Reeves, Z Kopp, et al. · Value in Health · 1
Pin13 Economic Evaluation of Voriconazole in the Treatment of Invasive Aspergillosis in Germany
2004 · J Jansen, W Kern, et al. · Value in Health · 1
PDF
Prs10 Prevalence of Pulmonary Hypertension in Germany–estimations Based on a Top-down Approach
2006 · B Ehlken, C Plesnila-Frank, et al. · Value in Health
PDF
818The cost and burden of illness caused by overactive bladder symptoms in the elderly in 5 European countries
2005 · P. Reeves, A. Lloyd, et al. · European Urology Supplements
Puk1 the Cost-effectiveness of Extended Release Tolterodine in the Management of Overactive Bladder in Germany and the United Kingdom
2004 · P Anderson, A Resch, et al. · Value in Health
PDF
Works count: 22
Citation count: 720
H-index: 10
I10-index: 10
Year
Topic
Type